A little heparin goes a long way: effect of therapeutic levels of unfractionated heparin on the heparin-induced thrombocytopenia-platelet factor 4 ELISA antibody assay

Jay S Raval^{1

2}, Nathan D Montgomery², Marian A Rollins-Raval¹

Affiliations

¹ Department of Pathology, University of New Mexico, Albuquerque, New Mexico.
² Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina, USA.

Jay S Raval et al. Blood Coagul Fibrinolysis. 2021.

. 2021 Jun 1;32(4):302-303.

doi: 10.1097/MBC.0000000000001034.

Jay S Raval^{1

2}, Nathan D Montgomery², Marian A Rollins-Raval¹

¹ Department of Pathology, University of New Mexico, Albuquerque, New Mexico.
² Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina, USA.

No abstract available

References

1. Cuker A, Arepally GM, Chong BH, Cines DB, Greinacher A, Gruel Y, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. Blood Adv 2018; 2:3360–3392.
1. Warkentin TE. Laboratory diagnosis of heparin-induced thrombocytopenia. Int J Lab Hematol 2019; 41: (Suppl. 1): 15–25.
1. McAvoy TJ. The biologic half-life of heparin. Clin Pharmacol Ther 1979; 25:372–379.
1. Northam KA, Chen S, Stivers A, Cicci JD, Hedrick TL, Rollins-Raval MA, Kasthuri RS. Impact of a multidisciplinary workflow on safety and management of patients with heparin-induced thrombocytopenia. J Health Syst Pharm 2021; 78:49–59.
1. Morel-Kopp MC, Mullier F, Gkalea V, Bakchoul T, Minet V, Elalamy I, Ward CM. subcommittee on platelet immunology. Heparin-induced multielectrode aggregometry method for heparin-induced thrombocytopenia testing: communication from the SSC of the ISTH. J Thromb Haemost 2016; 14:2548–2552.